Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial

By sjmartinez • June 28, 2024

Dehghani P, Srivatsav V, Vardeny O, Grewal J, Opotowsky AR, Muhll IV, Keir M, Ducas R, Singh J, Kim K, Joseph J, Aboulhosn J, Havighurst T, Hegde SM, Bhatt DL, Solomon S, Farkouh M, Goodman SG, Moe TG, Udell JA. Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial. JACC Adv. 2024 Mar 14;3(4):100897. doi: 10.1016/j.jacadv.2024.100897. PMID: 38939662; PMCID: PMC11198655.

Tags: adult congenital, Cardiology/Epi, Heart disease, Influenza, Publications, Vaccination

Bioresorbable, wireless dual stimulator for peripheral nerve regeneration

Ahn HY, Walters JB, Avila R, Oh S, Seo SG, Kim JU, Park J, Yoo S, Choi YS, Kim TY, Liu J, Yoo JY, Weissleder[...]

Incidence of positive genetic testing among patients referred for cardiac positron emission tomography

Trinh K, Dries A, Boulier K, Wang J. Incidence of positive genetic testing among patients referred for cardiac positron emission tomography. J Med Genet. 2025[...]

Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis

Li B, Elsten-Brown J, Li M, Zhu E, Li Z, Chen Y, Kang E, Ma F, Chiang J, Li YR, Zhu Y, Huang J, Fung[...]